Rosedale Medical Inc., a Cupertino, Calif.-based developer of glucose monitoring system for diabetics, has raised $20 million in Series C funding, according to a regulatory filing. U.S. Venture Partners and Investor Growth Capital were joined by return backers Pequot Ventures, Thomas McNerney & Partners and Versant Ventures. Sarnoff Corp. • which spun out Rosedale Medical in 2003 • also is a shareholder. (Source: PE Week)

VentureBeat

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
  • up-to-date information on the subjects of interest to you
  • our newsletters
  • gated thought-leader content and discounted access to our prized events, such as Transform 2021: Learn More
  • networking features, and more
Become a member